EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Metabolic reprogramming of efferocytosis in the tumour microenvironment: From apoptotic‐cell clearance to therapeutic targeting

Qianlu Yang iD, Jie Yan, Qianxi Yang

Clinical and Translational Medicine · 2026-02 · 16 (2)

DOI: 10.1002/ctm2.70601 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Clinical and Translational Medicine, online erschienen am 28.01.2026. Verfasst von Qianlu Yang und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Breast Surgery of the Third Affiliated Hospital of Kunming Medical University, Yunnan Cancer Hospital, Peking University Cancer Hospita…. Hauptthemen laut MEDLINE: Metabolic Reprogramming, Efferocytosis, Tumor Microenvironment, Apoptosis. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 259 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, Yunnan Provincial Health Commission Clinical Medicine Center Research Project, Yunnan Fundamental Research Kunming Medical University Projects.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Efferocytosis is a critical physiological process in which phagocytes clear apoptotic cells to maintain tissue homeostasis. However, within the tumour microenvironment (TME), this process is systematically hijacked by tumour cells, transforming it into a key pathological mechanism that drives immunosuppression, tumour progression and therapeutic resistance. Key findings This review systematically elucidates the central role of metabolic reprogramming in this functional reversal, emphasising that efferocytosis is essentially an immunometabolic intersection process precisely regulated by metabolism. By releasing various metabolites such as ATP, lactate, adenosine and sphingosine‐1‐phosphate (S1P), apoptotic tumour cells not only recruit tumour‐associated macrophages (TAMs) but also metabolically pre‐program their functions, inducing polarisation towards a pro‐tumourigenic M2‐like phenotype. During the recognition stage, tumour cells exploit metabolic abnormalities, such as glycosylation and lipid oxidation, to modify surface ‘eat‐me/don't‐eat‐me’ signals, thereby hijacking macrophage recognition and engulfment programs. Upon completion of engulfment, systemic reprogramming of amino acid, lipid and glucose metabolism occurs within macrophages. These metabolic alterations synergistically lock their immunosuppressive phenotype and establish a metabolic symbiosis between the tumour and stromal cells.

Conclusions

Based on these mechanisms, this review further explores translational strategies targeting the efferocytic–metabolic axis, aiming to reprogram the immunosuppressive efferocytosis into immune‐activating events to overcome TME‐mediated immunosuppression and enhance current therapeutic efficacy. By deeply dissecting the metabolic regulatory networks of efferocytosis, we aim to pave new directions for cancer immunotherapy, achieving a paradigm shift from ‘metabolic hijacking’ to ‘metabolic interventional therapy’.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Metabolic ReprogrammingEfferocytosisTumor MicroenvironmentApoptosisNeoplasmsHumansAnimalsMacrophages

Stichwörter der Autor:innen

Cancer immunotherapyEfferocytosisImmunometabolismMetabolic reprogrammingTumour microenvironment (TME)

Autor:innen und Institutionen

  • Department of Breast Surgery of the Third Affiliated Hospital of Kunming Medical University, Yunnan Cancer Hospital, Peking University Cancer Hospital Yunnan, Kunming, China.
  • Yunnan Eye Institute & Key Laboratory of Yunnan Province, Yunnan Eye Disease Clinical Medical Center, Affiliated Hospital of Yunnan University, Yunnan University, Kunming, China.

ORCID-Profile: Qianlu Yang

Förderung

  • National Natural Science Foundation of China
  • Yunnan Provincial Health Commission Clinical Medicine Center Research Project
  • Yunnan Fundamental Research Kunming Medical University Projects
  • Yunnan University Medical Research Foundation

Zitieren

APA

Yang, Q., Yan, J., & Yang, Q. (2026). Metabolic reprogramming of efferocytosis in the tumour microenvironment: From apoptotic‐cell clearance to therapeutic targeting. Clinical and Translational Medicine, 16(2). https://doi.org/10.1002/ctm2.70601

Vancouver

Yang Q, Yan J, Yang Q. Metabolic reprogramming of efferocytosis in the tumour microenvironment: From apoptotic‐cell clearance to therapeutic targeting. Clinical and Translational Medicine. 2026;16(2). doi:10.1002/ctm2.70601

BibTeX
@article{Yang2026,
  author = {Yang, Qianlu and Yan, Jie and Yang, Qianxi},
  title = {Metabolic reprogramming of efferocytosis in the tumour microenvironment: From apoptotic‐cell clearance to therapeutic targeting},
  journal = {Clinical and Translational Medicine},
  year = {2026},
  volume = {16},
  number = {2},
  doi = {10.1002/ctm2.70601}
}
Kostenlos starten →